articleTop 1% cited
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Nature · 2012 · Vol. 483(7391) · pp. 603–607
Jordi Barretina✉(Broad Institute)Giordano CaponigroNicolas Stransky(Broad Institute)K. VenkatesanAdam A. Margolin(Broad Institute)Sung Joon Kim(Genomics Institute of the Novartis Research Foundation)Christopher J. WilsonJoseph LehárGregory V. Kryukov(Broad Institute)Dmitriy SonkinAnupama ReddyManway LiuLauren Murray(Broad Institute)Michael F. Berger(Broad Institute)John E. MonahanPaula Morais(Broad Institute)Jodi MeltzerAdam Korejwa(Broad Institute)Judit Jané‐Valbuena(Harvard University)Felipa MapaJoseph Thibault(Genomics Institute of the Novartis Research Foundation)Eva Bric-FurlongPichai RamanAaron Shipway(Genomics Institute of the Novartis Research Foundation)Ingo H. Engels(Genomics Institute of the Novartis Research Foundation)Jill Cheng(Novartis (United States))Guoying Karen Yu(Novartis (United States))Jianjun Yu(Novartis (United States))Peter AspesiMelanie de SilvaKalpana JagtapMichael D. JonesLi WangCharlie Hatton(Dana-Farber Cancer Institute)Emanuele Palescandolo(Dana-Farber Cancer Institute)Supriya Gupta(Broad Institute)Scott Mahan(Broad Institute)Carrie Sougnez(Broad Institute)Robert C. Onofrio(Broad Institute)Ted Liefeld(Broad Institute)Laura E. MacConaill(Harvard University)Wendy Winckler(Broad Institute)Michael Reich(Broad Institute)Nanxin Li(Genomics Institute of the Novartis Research Foundation)Jill P. Mesirov(Broad Institute)Stacey Gabriel(Broad Institute)Gad Getz(Broad Institute)Kristin Ardlie(Broad Institute)Vivien W. Chan(Novartis (United States))Vic E. MyerBarbara L. WeberJeff PorterMarkus WarmuthPeter M. FinanJennifer L. Harris(Genomics Institute of the Novartis Research Foundation)Matthew Meyerson(Broad Institute)Todd R. Golub(Broad Institute)Michael MorrisseyWilliam R. SellersRobert SchlegelLevi A. Garraway(Broad Institute)
Cancer Genomics and DiagnosticsMelanoma and MAPK PathwaysProtein Degradation and InhibitorsCancerBiologyComputational biologyCancer researchBioinformaticsGenetics
MeSH terms
Antineoplastic AgentsChromosomes, HumanClinical Trials as TopicDrug Screening Assays, AntitumorEncyclopedias as TopicHumansModels, BiologicalNeoplasmsPharmacogeneticsPlasma CellsGenes, rasGenome, HumanGene Expression Regulation, NeoplasticDatabases, FactualSequence Analysis, DNA
Citations
8,404
FWCI
134.09
field-weighted impact
References
28
Percentile
100%
vs. same field & year
Citations per year
Cited by
Targeting folate receptor alpha for cancer treatment
Oncotarget · 2016 · 443 citations
The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology
Oncotarget · 2016 · 362 citations
Stability of the hybrid epithelial/mesenchymal phenotype
Oncotarget · 2016 · 460 citations
Cancer Cell Lines Are Useful Model Systems for Medical Research
Cancers · 2019 · 322 citations
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
British Journal of Cancer · 2015 · 699 citations
xCell: digitally portraying the tissue cellular heterogeneity landscape
Genome biology · 2017 · 4,570 citations
Serine, but Not Glycine, Supports One-Carbon Metabolism and Proliferation of Cancer Cells
Cell Reports · 2014 · 581 citations
Drug repurposing: progress, challenges and recommendations
Nature Reviews Drug Discovery · 2018 · 4,479 citations
References
Systematic variation in gene expression patterns in human cancer cell lines
Nature Genetics · 2000 · 2,090 citations
Regularization and Variable Selection Via the Elastic Net
Journal of the Royal Statistical Society Series B (Statistical Methodology) · 2005 · 20,431 citations
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Cancer Cell · 2006 · 3,214 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
